research-focus Research Focus International Scientific Journal Research Focus 2181-3833 Ilm-fan va innovatsiyalar akademiyasi 10.66073/researchfocus.v3i4.2674 REL-A-013608 14.00.00 ВЫЯВЛЕНИЕ РАННИХ НАРУШЕНИЙ СКОРОСТИ КЛУБОЧКОВОЙ ФИЛЬТРАЦИИ У БОЛЬНЫХ С ИНСУЛИНОРЕЗИСТЕНТНОСТЬЮ В ЗАВИСИМОСТИ ОТ СТЕПЕНИ ОЖИРЕНИЯ IDENTIFICATION OF EARLY DISORDERS OF GLOMERULAR FILTRATION RATE IN PATIENTS WITH INSULIN RESISTANCE DEPENDING ON THE DEGREE OF OBESITY INSULINREZISTENTLIGI BO‘LGAN BEMORLARDA SEMIZLIK DARAJASIGA BOG‘LIQ HOLDA KOPTOKCHALAR FILTRATSIYASI TEZLIGINING ERTA BUZILISHLARINI ANIQLASH Мамадиёрова Машхура Акбаровна Самаркандский Государственный Медицинский Университет, Республика Узбекистан, г.Самарканд 05 05 2024 2024 3 4 195 201 https://creativecommons.org/licenses/by/4.0 Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.

Хроническая сердечная недостаточность (ХСН) остаеця одной из наиболее актуальных медицинских и социально-экономических проблем, несмотря на значительный прогресс в лечении, так как прогноз этих больных остаеця неблагоприятным. Интенсивное изучение взаимосвязь между патологией сердечно-сосудистой системы и почками, привело к созданию концепции кардиоренального синдрома.

Chronic heart failure (CHF) remains one of the most pressing medical and socio-economic problems, despite significant progress in treatment, since the prognosis of these patients remains unfavorable. Intensive study of the relationship between the pathology of the cardiovascular system and the kidneys led to the creation of the concept of cardiorenal syndrome.

Surunkali yurak yetishmovchiligi (SYuYe) davolashda erishilgan sezilarli yutuqlarga qaramay, eng dolzarb tibbiy va ijtimoiy-iqtisodiy muammolardan biri bo‘lib qolmoqda, chunki bu bemorlarning prognozi noxushligicha qolmoqda. Yurak-qon tomir tizimi patologiyasi va buyraklar o‘rtasidagi o‘zaro bog‘liqlikni jadal o‘rganish kardiorenal sindrom konsepsiyasining yaratilishiga olib keldi.

 ХСН ХБП ССО СКФ CHF CKD CVS GFR SYuYe SBK YuQTA KFT Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol (2016) 4(11):913–21. 10.1016/s2213-8587(16)30162-0 Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet (2021) 398(10295):143–55. doi: 10.1016/S0140-6736(21)01324-6 Шилов Е.М. и др.Новые подходы к лечению больных хронической болезнью почек и метаболическим синдромом // Клиническая нефрология. 2012. № 2. С. 72–76.) Friedman AN, Kaplan LM, le Roux CW, Schauer PR. Management of obesity in adults with CKD. J Am Soc Nephrology (2021) 32(4):777–90. doi: 10.1681/ASN.2020101472 Tesauro M, Mascali A, Franzese O, Cipriani S, Cardillo C, Di Daniele N. Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin. Int J Hypertens (2012) 2012:943605. doi: 10.1155/2012/943605 Baylis D, Bartlett DB, Patel HP, Roberts HC. Understanding how we age: insights into inflammaging. Longevity Healthspan (2013) 2(1):8. doi: 10.1186/2046-2395-2-8 Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 122(7):481–6. doi: 10.7326/0003-4819-122- 7-199504010-00001 10.7326/0003-4819-122-7-199504010-00001 Ahima RS. Connecting obesity, aging and diabetes. Nat Med (2009) 15(9):996–7. doi: 10.1038/nm0909-996 Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, et al. Fat tissue, aging, and cellular senescence. Aging Cell (2010) 9(5):667–84. doi: 10.1111/j.1474- 9726.2010.00608.x 10.1111/j.1474-9726.2010.00608.x Robbins PD, Jurk D, Khosla S, Kirkland JL, LeBrasseur NK, Miller JD, et al. Senolytic drugs: Reducing senescent cell viability to extend health span. Annu Rev Pharmacol Toxicol (2021) 61:779–803. doi: 10.1146/annurev-pharmtox-050120-105018 Lair B, Laurens C, Van Den Bosch B, Moro C. Novel insights and mechanisms of lipotoxicity-driven insulin resistance. Int J Mol Sci [Internet] (2020) 21(17). doi: 10.3390/ijms21176358 Palmer AK, Tchkonia T, Kirkland JL. Targeting cellular senescence in metabolic disease. Mol Metab (2022) 66:101601. doi: 10.1016/j.molmet.2022.101601 Tzanavari T, Giannogonas P, Karalis KP. TNF-α and obesity. Current Directions in Autoimmunity (2010) 11:145–156. doi: 10.1159/000289203 Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature (1997) 389(6651):610–4. doi: 10.1038/39335 Lim CC, Teo BW, Tai ES, Lim SC, Chan CM, Sethi S, et al. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. PloS One (2015) 10(3):e0122009. doi: 10.1371/journal.pone.0122009 Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrology (2006) 17(9):2599. doi: 10.1681/ASN.2006040331 CrossRef Full Text | Google Scholar Porrini E., Bayes B., Diaz Juan M. et al. Hyperinsulinemia and hyperfiltration in renal transplantation // Transplantation. 2009. Vol. 87. № 2. P. 274–279. 10.1097/tp.0b013e318191a7d5 Suh SH, Oh TR, Choi HS, Kim CS, Lee J, Oh YK, et al. Association of high serum adiponectin level with adverse cardiovascular outcomes and progression of coronary artery calcification in patients with pre-dialysis chronic kidney disease. Front Cardiovasc Med (2021) 8:789488. doi: 10.3389/fcvm.2021.789488PubMed Abstract | CrossRef Full Text | Google Scholar Halberg N, Schraw TD, Wang ZV, Kim JY, Yi J, Hamilton MP, et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes (2009) 58(9):1961–70. doi: 10.2337/db08-1750 Агабабян Ирина Рубеновна and Юсупова Зумрад Кадамбоевна. Сурункали буйрак етишмовчилиги билан боғлиқ сурункали юрак етишмовчилигининг клиник хусусиятлари. Журнал Проблемы биологии и медицины. 2022. № 6 (140)(декабрь. 2022), 26–30.